Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Doximity ( (DOCS) ) has provided an update.
On December 24, 2025, Doximity, Inc. and certain of its directors and officers reached a proposed settlement agreement to resolve a securities litigation case pending in the U.S. District Court for the Northern District of California. The agreement calls for a $31 million aggregate settlement payment, to be fully funded by insurance, and provides for the dismissal of all claims against the company and the named individuals without any admission of liability, fault, or wrongdoing, subject to stockholder notification, court approval, and other customary conditions, potentially removing a significant legal overhang for the company and its stakeholders.
The most recent analyst rating on (DOCS) stock is a Buy with a $65.00 price target. To see the full list of analyst forecasts on Doximity stock, see the DOCS Stock Forecast page.
Spark’s Take on DOCS Stock
According to Spark, TipRanks’ AI Analyst, DOCS is a Outperform.
Doximity’s overall stock score is driven by its strong financial performance and positive earnings call, which highlight robust growth and profitability. However, bearish technical indicators and a high valuation relative to earnings temper the score.
To see Spark’s full report on DOCS stock, click here.
More about Doximity
Doximity, Inc. operates in the digital healthcare and telehealth industry, providing an online professional network and related digital tools primarily for medical professionals, with a market focus on connecting physicians and supporting clinical communication and workflow.
Average Trading Volume: 2,156,558
Technical Sentiment Signal: Sell
Current Market Cap: $8.33B
For detailed information about DOCS stock, go to TipRanks’ Stock Analysis page.